{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:31:46Z","timestamp":1789939906029,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00270-016-1535-7","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T20:53:35Z","timestamp":1483044815000},"page":"394-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere\u00a0+\u00a0ZAnosaR) Study"],"prefix":"10.1007","volume":"40","author":[{"given":"Jean-Pierre","family":"Pelage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Fohlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Beauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"1535_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"GA Kaltsas","year":"2004","unstructured":"Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25:458\u2013511.","journal-title":"Endocr Rev"},{"key":"1535_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","volume":"79","author":"IM Modlin","year":"1997","unstructured":"Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813\u201329.","journal-title":"Cancer"},{"key":"1535_CR3","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/01.RVI.0000232177.57950.71","volume":"7","author":"DC Madoff","year":"2006","unstructured":"Madoff DC, Gupta S, Ahrar K, et al. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol. 2006;7:1235\u201349.","journal-title":"J Vasc Interv Radiol"},{"key":"1535_CR4","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/j.1572-0241.2000.03210.x","volume":"95","author":"M Ducreux","year":"2000","unstructured":"Ducreux M, Ruszniewski P, Chayvialle JA, et al. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol. 2000;95:3276\u2013381.","journal-title":"Am J Gastroenterol"},{"key":"1535_CR5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359.","journal-title":"Cancer"},{"key":"1535_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.coc.0000135343.06038.eb","volume":"27","author":"AD McCollum","year":"2004","unstructured":"McCollum AD, Kulke MH, Ryan DP, et al. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors. Am J Clin Oncol. 2004;27:485\u20138.","journal-title":"Am J Clin Oncol"},{"key":"1535_CR7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.0.CO;2-P","volume":"86","author":"PN Cheng","year":"1999","unstructured":"Cheng PN, Saltz LB. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma. Cancer. 1999;86:944\u20138.","journal-title":"Cancer"},{"key":"1535_CR8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-120-4-199402150-00008","volume":"120","author":"CG Moertel","year":"1994","unstructured":"Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994;120:302\u20139.","journal-title":"Ann Intern Med"},{"key":"1535_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiology.189.2.7692465","volume":"189","author":"E Therasse","year":"1993","unstructured":"Therasse E, Breittmayer F, Roche A, et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology. 1993;189:541\u20137.","journal-title":"Radiology"},{"key":"1535_CR10","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.21389","volume":"104","author":"S Gupta","year":"2005","unstructured":"Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer. 2005;104:1590\u2013602.","journal-title":"Cancer"},{"key":"1535_CR11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jvir.2007.04.018","volume":"18","author":"AT Ruutiainen","year":"2007","unstructured":"Ruutiainen AT, Soulen MC, Tuite CM, et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol. 2007;18:847\u201355.","journal-title":"J Vasc Interv Radiol"},{"key":"1535_CR12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jvir.2008.01.030","volume":"19","author":"T Baere de","year":"2008","unstructured":"de Baere T, Deschamps F, Teriitheau C, et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol. 2008;19:855\u201361.","journal-title":"J Vasc Interv Radiol"},{"key":"1535_CR13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","volume":"13","author":"A Roche","year":"2003","unstructured":"Roche A, Girish BV, de Baere T, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 2003;13:136\u201340.","journal-title":"Eur Radiol"},{"key":"1535_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjc.6603526","volume":"96","author":"F Marrache","year":"2007","unstructured":"Marrache F, Vullierme MP, Roy C, et al. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer. 2007;96:49\u201355.","journal-title":"Br J Cancer"},{"key":"1535_CR15","first-page":"541","volume":"17","author":"A Laurent","year":"1996","unstructured":"Laurent A, Beaujeux R, Wassef M, et al. Trisacryl microspheres for therapeutic embolization: development and in vitro evaluation. AJNR Am J Neuroradiol. 1996;17:541\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1535_CR16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s10620-007-9995-x","volume":"53","author":"NB Amesur","year":"2008","unstructured":"Amesur NB, Zajko AB, Carr BI. Chemoembolization for unresectable hepatocellular carcinoma with different sizes of embolization particles. Dig Dis Sci. 2008;53:1400\u20134.","journal-title":"Dig Dis Sci"},{"key":"1535_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Valera","year":"2007","unstructured":"Valera M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46:474\u201381.","journal-title":"J Hepatol"},{"key":"1535_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00042737-200012020-00004","volume":"12","author":"S Dominguez","year":"2000","unstructured":"Dominguez S, Denys A, Madeira I, et al. Hepatic arterial chemoembolization with streptozocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol. 2000;12:151\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1535_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","volume":"31","author":"AS Kennedy","year":"2008","unstructured":"Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin Y90-microspheres: early results in 148 patients. Am J Clin Oncol. 2008;31:271\u20139.","journal-title":"Am J Clin Oncol"},{"key":"1535_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2011.07.041","volume":"83","author":"K Memon","year":"2012","unstructured":"Memon K, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys. 2012;83:887\u201394.","journal-title":"Int J Radiat Oncol Biol Phys"}],"updated-by":[{"DOI":"10.1007\/s00270-017-1573-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000}}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-016-1535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-016-1535-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-016-1535-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T10:39:21Z","timestamp":1601289561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-016-1535-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1535"],"URL":"https:\/\/doi.org\/10.1007\/s00270-016-1535-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00270-017-1573-9","asserted-by":"object"}]},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}